Gary M. Rauch

CIK: 0001597530

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TNFA

TNF Pharmaceuticals, Inc.

Discretionary Trading P&L

Holdings

Transaction History (3 total)

QCLS
Q/C TECHNOLOGIES, INC.
Nov 14, 2025
Award(A)
Direct
11.4K shares-
QCLS
Q/C TECHNOLOGIES, INC.
Oct 3, 2025
Award(A)
Direct
1.1K shares-
TNFA
TNF Pharmaceuticals, Inc.
Apr 17, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
75K shares-

		Type	Shares	Price		Ownership
Nov 14, 2025	QCLS Q/C TECHNOLOGIES, INC.	Award(A)	11,420	-	-	Direct
Oct 3, 2025	QCLS Q/C TECHNOLOGIES, INC.	Award(A)	1,080	-	-	Direct
Apr 17, 2025	TNFA TNF Pharmaceuticals, Inc.	Award(A) Employee Stock Option (Right to Buy)	75,000	-	-	Direct

1-3 of 3 transactions

About RAUCH GARY M

RAUCH GARY M (SEC CIK 0001597530) files insider reports with the SEC as TNF Pharmaceuticals, Inc. (TNFA).

Signal8 holds 3 ownership filings by RAUCH GARY M, all Form 4s, filed between Apr 18, 2025 and Nov 14, 2025. Those filings report 3 transactions, from Apr 17, 2025 to Nov 14, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on RAUCH GARY M's filings is in NEW YORK, NY.

Recent filings by RAUCH GARY M

Nov 14, 2025: Grant or award of QCLS shares (Form 4, code A).
Oct 3, 2025: Grant or award of QCLS shares (Form 4, code A).
Apr 17, 2025: Grant or award of TNFA derivative securities (Form 4, code A).

Other insiders filing for TNF Pharmaceuticals, Inc. (TNFA)

RHODES IAN THOMAS, Interim CFO

How to read Form 4 transaction codes